Stay ahead with
clearer skin and less itch

DUPIXENT in combination with a topical corticosteroid was studied in a 16-week clinical trial in 367 patients ages 6-11 years with severe eczema not adequately controlled with topical prescription treatments.

 

DUPIXENT results
in children

From a clinical trial at 16 weeks (DUPIXENT* + topical corticosteroids [TCS] vs TCS only):

~2X
SAW CLEAR OR
ALMOST CLEAR SKIN

30% 300 mg DUPIXENT every 4 weeks
+ TCS vs 13% TCS only

39% 200 mg DUPIXENT every 2 weeks
+ TCS vs 10% TCS only

~4.5X
HAD noticeably
LESS ITCH

54% 300 mg DUPIXENT every 4 weeks
+ TCS vs 12% TCS only

61% 200 mg DUPIXENT every 2 weeks
+ TCS vs 13% TCS only

≥75%
Clearer skin in
more
than half of
children

75% 300 mg DUPIXENT every 4 weeks + TCS
vs 28% TCS only

75% 200 mg DUPIXENT every 2 weeks + TCS vs
26% TCS only

Your healthcare provider will tell you how much DUPIXENT to inject and how often.

*After an initial loading dose of 2 injections, children less than 66 lb received 300 mg every 4 weeks; children 66 lb or more received 200 mg every 2 weeks.

 

View BEFORE AND AFTER
PHOTOS IN CHILDREN

Click and drag
to see results dragging icon

Before
Treatment

After treatment
with dupixent
at 16 weeks

Click and drag
to see results dragging icon

Before
Treatment

After treatment
with dupixent
at 16 weeks

Actual 10-year-old (left) and 9-year-old (right) clinical trial patients treated with DUPIXENT and a topical corticosteroid. These patients met clinical trial criteria for clear or almost clear skin. Individual results may vary.

LONG-TERM SAFETY
RESULTS IN CHILDREN

Long-term safety results for children continuing on DUPIXENT with or without TCS in the pediatric extension study through 1 year were consistent with the adult clinical trials.

MOST COMMON SIDE
EFFECTS INCLUDE:

  • Injection site reactions
  • Eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision
  • Dry eye
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

View the possible side effects of DUPIXENT

What You Should Know About the Patients in this Study:

100%
Had severe
atopic dermatitis
~8.5 years
Average age
~58%
Average body surface
area involvement

Have you spoken to a dermatologist or allergist about DUPIXENT?

Go back

Great! Sign up for DUPIXENT MyWay®, our patient support program, to access program benefits and get one-on-one support every step of the way, including help with filling your first prescription.

Enroll in DUPIXENT MyWay

If you're still struggling with moderate-to-severe eczema, maybe it's time to change the conversation.

WATCH A VIDEO ON ASKING ABOUT DUPIXENT

Answer a few short questions about your eczema symptoms and treatment goals. We’ll turn it into a personalized guide you can use at your next visit.

Get Started

Specialists like dermatologists or allergists often have more experience treating moderate-to-severe eczema and can help create a personalized care plan for you.

Find a Specialist Near Me
DID YOU KNOW?
DUPIXENT is not a steroid
or immunosuppressant

I’m really proud of Catch taking
his DUPIXENT injection. At first,
he resisted, but now he sees
the benefits of taking
DUPIXENT.

Amber,

DUPIXENT MyWay® Caregiver and Patient
Ambassador. Individual results may vary.

WATCH MORE
CAREGIVER STORIES